Study

You may benefit from

Vitamin K2
Newsletter

They gave cancer patients 2000 IU vitamin D3 a day for 12 weeks to see if it lowers inflammation.

By OxidativeState · · 1 min read

PubMed: Effects of personalized vitamin D(3) on inflammation in colorectal cancer patients: a randomized trial

They gave cancer patients 2000 IU vitamin D3 a day for 12 weeks to see if it lowers inflammation.
the results?

Vitamin D3 lowered levels of Interleukin-6 (IL-6), a major inflammatory biomarker that forms a feedback cycle with estrogen and PTH.

The study in brief

Does vitamin D3 lower IL-6 in colorectal cancer patients?

In colorectal cancer patients with low vitamin D, 12 weeks of vitamin D3 lowered serum IL-6 by 39.3% compared with placebo (p = 0.001).

Who was studied
126 colorectal cancer patients in Germany, operated on in the past year, with serum 25-hydroxyvitamin D below 60 nmol/L.
What they did
A randomized, double-blind trial gave a personalized loading dose of vitamin D3, then 2000 IU a day (61 patients), or placebo (65 patients) for 12 weeks.
What they found
The 95% confidence interval for the IL-6 reduction was -54.9% to -18.2%. IFN-gamma (-6.7%, p = 0.69) and MMP-1 (-5.4%, p = 0.23) did not change significantly.
What it does not show
The study measured three blood markers over 12 weeks, not tumor growth, recurrence or survival. The trial is still ongoing.
Note on the post above
The abstract does not mention estrogen or PTH, and patients got a personalized loading dose before the 2000 IU a day.

Summary written from the PubMed abstract, not from the full paper.

The study

  1. Effects of personalized vitamin D(3) on inflammation in colorectal cancer patients: a randomized trialBr J Cancer · 2026 · PMID 41507560
Read on X ↗

Get the next article in your inbox

Join the free newsletter. Science-backed health, no spam.